Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Limits of quantitative evaluation methods].

P Coumel, J F Leclercq, P Attuel

    Archives Des Maladies Du Coeur Et Des Vaisseaux
    |December 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transvenous cryo-ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a single-centre initial experience study.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2007
    Same author

    [Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology].

    Archives des maladies du coeur et des vaisseaux·2006
    Same author

    [Hypertension and age over 70 years are the two most important risk factors for stroke in patients with atrial fibrillation].

    Annales de cardiologie et d'angeiologie·2004
    Same author

    [Atrial vulnerability: a new protocol by bigeminy pacing].

    Annales de cardiologie et d'angeiologie·2003
    Same author

    [Indications of automatic ventricular implantable defibrillator. Implications for daily practice].

    Annales de cardiologie et d'angeiologie·2003
    Same author

    [Holter monitoring in 2000].

    Archives des maladies du coeur et des vaisseaux·2001
    Same journal

    Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Alterations in coronary circulation during aortic insufficiency in young subjects.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Cardio-esophageal auscultation.

    Archives des maladies du coeur et des vaisseaux·2010
    Same journal

    Hypertensive accidents following the injection of acetylcholine.

    Archives des maladies du coeur et des vaisseaux·2010
    See all related articles

    Holter monitoring limitations exclude major arrhythmias, hindering antiarrhythmic drug research. Current quantification methods for ventricular extrasystoles are biased, leading to unreliable data and overlooking critical cardiac conditions.

    Area of Science:

    • Cardiology
    • Clinical Electrophysiology
    • Pharmacology

    Background:

    • Holter monitoring typically quantifies only atrial and ventricular extrasystoles.
    • Benign atrial extrasystoles are often overlooked in antiarrhythmic drug studies.
    • Current methods for quantifying ventricular extrasystoles are prone to significant biases.

    Purpose of the Study:

    • To highlight the limitations of current Holter monitoring protocols in assessing cardiac arrhythmias.
    • To address the systematic disregard of major arrhythmias in quantitative studies.
    • To emphasize the need for improved quantification methods for antiarrhythmic drug research.

    Main Methods:

    • Critical review of existing Holter monitoring quantification techniques.
    • Analysis of biases in assessing ventricular extrasystoles (e.g., QRS morphology, coupling interval).

    Related Experiment Videos

  • Examination of literature regarding arrhythmia quantification and antiarrhythmic drug efficacy.

    • Main Results:

    • Holter monitoring technical constraints exclude major arrhythmias like atrial fibrillation and ventricular tachycardias.
    • Quantitative protocols often ignore crucial parameters like QRS morphology and coupling intervals, leading to bias.
    • The focus on easily quantifiable minor arrhythmias is a flawed approach, as key parameters remain poorly understood.

    Conclusions:

    • Standardized Holter monitoring protocols fail to capture clinically significant arrhythmias, impacting antiarrhythmic drug development.
    • Existing quantification methods for ventricular extrasystoles are unreliable and introduce bias, complicating prognosis assessment.
    • Further research is needed to develop robust methods for quantifying major arrhythmias and their impact on cardiac health.